ALLOTRX BIO
Live / Applied — Second extension granted (statement of use) (as of 11 Dec 2025)
What this means for you
Not registered yet, but its 15 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98316738
- Mark type
- Stylized text
- Filed
- 15 Dec 2023
- Published for opposition
- 27 Aug 2024
- Attorney of record
- Robert Kost
Goods and services
- Class 005 — Pharmaceuticals: Anti-inflammatory preparations; Cells for medical use; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the treatment of infectious diseases; Stem cells for medical purposes
Owner
- AlloTRx Bio, Pittsburgh, PA, US
- AlloTRx Bio, Pittsburgh, PA, US
Prosecution history
- 11 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Dec 2025 — SOU EXTENSION 2 GRANTED
- 21 Oct 2025 — SOU EXTENSION 2 FILED
- 05 Dec 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 05 Dec 2025 — NOTICE OF REVIVAL - E-MAILED
- 05 Dec 2025 — PETITION TO REVIVE-GRANTED
- 05 Dec 2025 — TEAS PETITION TO REVIVE RECEIVED
- 24 Nov 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 24 Nov 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jul 2025 — SOU EXTENSION 1 GRANTED
- 21 Apr 2025 — SOU EXTENSION 1 FILED
- 27 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 May 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 26 May 2025 — NOTICE OF REVIVAL - E-MAILED